BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37306783)

  • 1. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for
    Peterson AB; Mirando DM; Dewaraja YK
    EJNMMI Res; 2023 Jun; 13(1):57. PubMed ID: 37306783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in clinical patients and realistic simulations.
    Peterson AB; Mirando DM; Dewaraja YK
    Res Sq; 2023 Apr; ():. PubMed ID: 37131738
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-Time-Point Imaging for Dosimetry After [
    Wang C; Peterson AB; Wong KK; Roseland ME; Schipper MJ; Dewaraja YK
    J Nucl Med; 2023 Sep; 64(9):1463-1470. PubMed ID: 37500260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and reproducibility of simplified QSPECT dosimetry for personalized
    Del Prete M; Arsenault F; Saighi N; Zhao W; Buteau FA; Celler A; Beauregard JM
    EJNMMI Phys; 2018 Oct; 5(1):25. PubMed ID: 30318563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in
    Rinscheid A; Kletting P; Eiber M; Beer AJ; Glatting G
    Med Phys; 2019 Dec; 46(12):5861-5866. PubMed ID: 31587333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After
    Devasia TP; Dewaraja YK; Frey KA; Wong KK; Schipper MJ
    J Nucl Med; 2021 Aug; 62(8):1118-1125. PubMed ID: 33443063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Single-Time-Point Estimates of
    Chicheportiche A; Sason M; Zidan M; Godefroy J; Krausz Y; Gross DJ; Grozinsky-Glasberg S; Ben-Haim S
    J Nucl Med; 2023 Oct; 64(10):1610-1616. PubMed ID: 37500259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies.
    Hou X; Brosch J; Uribe C; Desy A; Böning G; Beauregard JM; Celler A; Rahmim A
    J Nucl Med; 2021 Jul; 62(7):1006-1011. PubMed ID: 33127625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sampling schedules on [
    Rinscheid A; Kletting P; Eiber M; Beer AJ; Glatting G
    EJNMMI Phys; 2020 Jun; 7(1):41. PubMed ID: 32556844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points.
    Chen G; Lu Z; Jiang H; Afshar-Oromieh A; Rominger A; Shi K; Mok GSP
    Front Med (Lausanne); 2023; 10():1246881. PubMed ID: 38020081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After
    Dewaraja YK; Mirando DM; Peterson AB; Niedbala J; Millet JD; Mikell JK; Frey KA; Wong KK; Wilderman SJ; Nelson AS
    J Nucl Med; 2022 Nov; 63(11):1665-1672. PubMed ID: 35422445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [
    Hardiansyah D; Yousefzadeh-Nowshahr E; Kind F; Beer AJ; Ruf J; Glatting G; Mix M
    J Nucl Med; 2024 Apr; 65(4):566-572. PubMed ID: 38423787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for [Formula: see text]Lu-DOTATATE therapy.
    Vergnaud L; Giraudet AL; Moreau A; Salvadori J; Imperiale A; Baudier T; Badel JN; Sarrut D
    EJNMMI Phys; 2022 May; 9(1):37. PubMed ID: 35575946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized radiation dosimetry for PRRT-how many scans are really required?
    Freedman N; Sandström M; Kuten J; Shtraus N; Ospovat I; Schlocker A; Even-Sapir E
    EJNMMI Phys; 2020 May; 7(1):26. PubMed ID: 32394075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Single-Time-Point Image-Based Dosimetry of
    Brosch-Lenz J; Delker A; Völter F; Unterrainer LM; Kaiser L; Bartenstein P; Ziegler S; Rahmim A; Uribe C; Böning G
    J Nucl Med; 2023 May; 64(5):767-774. PubMed ID: 36657980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized dosimetry of
    Carter LM; Ocampo Ramos JC; Kesner AL
    Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34271565
    [No Abstract]   [Full Text] [Related]  

  • 17. Dependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling schedule.
    Maaß C; Sachs JP; Hardiansyah D; Mottaghy FM; Kletting P; Glatting G
    EJNMMI Res; 2016 Dec; 6(1):30. PubMed ID: 27015662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant
    Parghane RV; Bhandare M; Chaudhari V; Ostwal V; Ramaswamy A; Talole S; Shrikhande SV; Basu S
    J Nucl Med; 2021 Nov; 62(11):1558-1563. PubMed ID: 33637590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a
    Zhao W; Esquinas PL; Frezza A; Hou X; Beauregard JM; Celler A
    Phys Med Biol; 2019 Aug; 64(17):175006. PubMed ID: 31287093
    [No Abstract]   [Full Text] [Related]  

  • 20. Practical kidney dosimetry in peptide receptor radionuclide therapy using [
    Staanum PF; Frellsen AF; Olesen ML; Iversen P; Arveschoug AK
    EJNMMI Phys; 2021 Nov; 8(1):78. PubMed ID: 34773508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.